Problems of anti-tuberculosis therapy in patients on hemodialysis

Problems of anti-tuberculosis therapy in patients on hemodialysis

The objective: to determine possibility of prescribing and safety of various anti-tuberculosis drugs and their combinations as part of a therapeutic or preventive course of anti-tuberculosis therapy (ATBT) in patients with end-stage chronic kidney disease (CKD) receiving hemodialysis replacement the...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. M. Gordeeva, A. M. Tikhonov, S. N. Andreevskaya, E. E. Larionova, N. L. Karpina
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2022-07-01
Series:	Туберкулез и болезни лёгких
Subjects:	anti-tuberculosis therapy hemodialysis drug resistance of tuberculous mycobacteria adverse events
Online Access:	https://www.tibl-journal.com/jour/article/view/1647
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A CLINICAL CASE OF EFFECTIVE TREATMENT OF EXTENSIVE DRUG RESISTANCE TUBERCULOSIS WITH NEW ANTI-TUBERCULOSIS DRUGS
by: M. V. Pаvlovа, et al.
Published: (2018-01-01)

Unfavorable side effects to first line anti-tuberculosis drugs
by: N. A. Stepanova, et al.
Published: (2016-05-01)

FREQUENCY AND CHARACTERISTICS OF ADVERSE REACTIONS TO SECOND LINE ANTI-TUBERCULOSIS DRUGS IN THOSE ILL WITH MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: A. A. Toktogonova
Published: (2017-11-01)

ANALYSIS OF MUTATIONS OF TUBERCULOUS MYCOBACTERIA DEFINING DRUG RESISTANCE IN HIV POSITIVE AND HIV NEGATIVE TUBERCULOSIS PATIENTS WITHOUT PRIOR HISTORY OF TREATMENT IN SVERDLOVSK REGION
by: G. V. Panov, et al.
Published: (2017-02-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01)

Mycobacteria Presence and Anti-Tuberculosis Drug Resistance Profile in Düzce Region: 18 Years of Experience
by: Emel Akbaş, et al.
Published: (2025-04-01)

Nephrotoxic characteristics of anti-tuberculosis drugs
by: G. N. Mozhokina, et al.
Published: (2019-11-01)

CLINICAL CASE OF EFFECTIVE HOLISTIC TREATMENT OF BILATERIAL FIBROUS CAVERNOUS PULMONARY TUBERCULOSIS
by: G. Yu. Marfina, et al.
Published: (2017-03-01)

The problem of neurotoxicity of drugs in the treatment of tuberculosis patients
by: G. N. Mozhokina, et al.
Published: (2020-11-01)

IMPACT OF BEDAQUILINE ON THE EFFICIENCY OF COMPREHENSIVE THERAPY OF RESPIRATORY TUBERCULOSIS
by: M. N. Kondakova, et al.
Published: (2018-07-01)

DETECTION AND DIFFERENTIATION OF NON-TUBERCULOUS MYCOBACTERIA AND M. TUBERCULOSIS COMPLEX BY REAL TIME PCR
by: V. V. Ustinova, et al.
Published: (2016-09-01)

DETECTION OF NON-TUBERCULOUS MYCOBACTERIA IN MARI EL REPUBLIC
by: L. V. Petrovа, et al.
Published: (2018-03-01)

EPIDEMIC SITUATION AND TREATMENT PROSPECTS OF MULTIPLE RESISTANT TUBERCULOSIS IN KANTY-MANSIYSKY AUTONOMOUS REGION
by: E. S. Ershovа, et al.
Published: (2018-05-01)

EXPERIENCE OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS PATIENTS WITH BEDAQUILINE IN AMUR REGION
by: L. Yu. Tikhonova, et al.
Published: (2018-07-01)

TO DISCONTINUE OR TO WAIT?: INDICATIONS FOR DISCONTINUATION OF ANTI-TUBERCULOSIS DRUGS DUE TO ADVERSE EVENTS
by: D. A. Ivаnovа, et al.
Published: (2018-03-01)

Gene mutation and drug resistance of <i>M. tuberculosis</i> in the patients followed up in the city of Moscow
by: M. A. Krasnova, et al.
Published: (2020-01-01)

Frequency and characteristics of adverse events caused by anti-tuberculosis drugs in pulmonary tuberculosis patients with diabetes myelitis
by: O. G. Komissarova, et al.
Published: (2020-03-01)

EFFICIENCY OF PULMONARY TUBERCULOSIS CHEMOTHERAPY IN NEW CASES DEPENDING ON THE TIME OFDRUG RESISTANCE DETECTION
by: M. V. Burаkovа, et al.
Published: (2017-12-01)

Comparative analysis of eﬃcacy and safety of various anti-tuberculosis therapy regimens in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2022-06-01)

Frequency of M. tuberculosis strains with different drug resistance profiles among pulmonary tuberculosis patients in the Kyrgyz Republic in 2016
by: A. A. Toktogonovа, et al.
Published: (2018-10-01)

Safety of treatment regimens in multiple drug resistant tuberculosis patients compiled as per the new WHO recommendations as of 2019
by: D. A. Ivanova, et al.
Published: (2020-02-01)

Drug susceptibility of low growing non-tuberculous mycobacteria
by: S. N. Аndreevskaya, et al.
Published: (2016-04-01)

Prospects for Expanding Drug Therapy for Multiple Drug Resistant and Extensively Drug Resistant Tuberculosis
by: G. N. Mozhokina, et al.
Published: (2022-04-01)

Extrapulmonary Comparisons Between Mycobacterium Tuberculosis and Non-Tuberculous Mycobacteria: From Manifestations and Diagnosis to Treatment
by: Dong Q, et al.
Published: (2025-05-01)

Specific Parameters of Toxic Reactions in Rats to the Combination of Delamanid and Drugs for Treatment of Drug Resistant Tuberculosis (A Pilot Study)
by: G. N. Mozhokina, et al.
Published: (2023-04-01)

Clofazimine: History and Perspectives
by: G. N. Mozhokina, et al.
Published: (2021-06-01)

DETECTION OF TUBERCULOUS MYCOBACTERIA IN THE BLOOD OF PATIENTS WHEN SUSPECTING TUBERCULOUS SEPSIS
by: V. N. Zimina, et al.
Published: (2016-08-01)

Miru-vntr technique for molecular epidemiological studies of tuberculosis
by: E. V. Аntusheva, et al.
Published: (2016-04-01)

Non-tuberculous mycobacteria and other acid fast bacilli pathogens identification by qPCR and MALDI-ToF MS in tuberculosis-like lesions of slaughtered cattle from Ecuador
by: Solon Alberto Orlando, et al.
Published: (2025-07-01)

Prevalence, clinical reasons and associated factors of extended treatment duration for drug susceptible tuberculosis – a real-world experience
by: Chih-Yu Liu, et al.
Published: (2025-04-01)

Application value of nucleic acid MALDI-TOF MS in mycobacterial species identification and drug resistance detection in Mycobacterium tuberculosis
by: Xiaofang Liu, et al.
Published: (2025-05-01)

Detection of Non-Tuberculous Mycobacteria and Treatment of Mycobacteriosis in Arkhangelsk Oblast in 2010–2020
by: P. I. Eliseev, et al.
Published: (2024-11-01)

THE ANTI-TUBERCULOSIS ANTIBIOTIC OF RIFAPENTINE: PERSPECTIVES OF CLINICAL USE
by: A. G. Samoylova, et al.
Published: (2019-01-01)

Clinical characteristics of acquired anti-IFN-γ autoantibodies in patients infected with non-tuberculous mycobacteria: a prospective cohort study
by: Hanlin Liang, et al.
Published: (2025-02-01)

DETECTION OF TUBERCULOUS MYCOBACTERIA IN SPUTUM AND INTENSITY OF BACILLARY EXCRETION IN TUBERCULOSIS PATIENTS WITH VARIOUS HIV STATUS
by: V. N. Ziminа, et al.
Published: (2017-08-01)

Clinicopathological characteristics and diagnostic performance of metagenomic pathogen detection technology in mycobacterial infections among HIV patients
by: Man Li, et al.
Published: (2025-04-01)

Clinical correlation study of non-tuberculous mycobacterial isolates from bronchoalveolar lavage fluid
by: Hongye Ning, et al.
Published: (2025-03-01)

Etiological Diagnosis of Infectious Coxitis Depending on the Patient's HIV Status
by: I. A. Gerasimov, et al.
Published: (2023-01-01)

Mycobacteriophage-based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteria
by: M. B. Lapenkova, et al.
Published: (2020-09-01)

A new in vitro dormancy model of <i>Mycobacterium tuberculosis</i>
by: Ya. R. Bаtyrshinа, et al.
Published: (2020-04-01)